Zoobba is a renowned brand in the pharmaceutical industry, offering a wide range of products and services. Formerly known as Zhongnan Pharmaceutical Factory, it was established in 1968 and is located in Shuangqing District, Shaoyang City, Hunan Province, China. With a sprawling area of 200,000 square meters and total assets worth 135 million yuan, Zoobba holds the export and import rights for independent products and technologies.

It is one of the 38 key pharmaceutical enterprises in China and serves as a national chemical raw material production base. Since its restructuring in July 2003, Zoobba has undergone significant transformations, meeting the rigorous requirements of Good Manufacturing Practices (GMP). The company successfully obtained GMP certification in 2004, making it one of the first enterprises in Shaoyang City and earlier in Hunan Province to achieve this milestone.

With more than ten production lines for various formulations, Zoobba boasts advanced testing instruments and strictly adheres to the latest national GMP standards in its manufacturing processes. The company's focus lies in the production of tablets, capsules, granules, creams, hormone preparations, and active pharmaceutical ingredients. Zoobba takes pride in its quality management system, continually improving it to deliver exceptional products.

Several of their products, including aspirin, sulpiride tablets, olanzapine tablets, and compound n-propylamine tablets, have been honored with provincial and ministerial awards. The formulation workshop has an annual production capacity of up to one billion tablets. Today, Zoobba has evolved into a comprehensive enterprise, integrating research and development, production, and sales of active pharmaceutical ingredients, formulations, and pharmaceutical intermediates.

The product portfolio of Zoobba includes 34 formulations, such as compound n-propylamine tablets, aspirin tablets, sulpiride tablets, and olanzapine tablets. Among these, 14 formulations and specifications have been chosen to be included in the National Essential Medicines List. The company also produces active pharmaceutical ingredients like aspirin, sulpiride, and olanzapine, as well as pharmaceutical intermediates such as acar and acar hydrochloride.

Zoobba's products find applications in the treatment of psychiatric disorders, liver diseases, gastric disorders, colds, and pain relief. The high-quality products are well-received across the country, earning praise from a wide customer base. By establishing modern corporate systems and ensuring strict internal management, Zoobba has laid a solid foundation for its development.

Simultaneously, the company has assembled a robust research team to foster technological innovation. Recognized as one of the 60 key cultivated companies for listing in Hunan Province and one of the first 19 supported companies for listing, Zoobba strives to achieve success in the Small and Medium Enterprises (SME) board market during the Thirteenth Five-Year Plan period. With its dedication to excellence and continuous advancements, Zoobba aims to contribute to the healthcare industry and serve the needs of its customers effectively